Value of α-smooth muscle actin and glial fibrillary acidic protein in predicting early hepatic fibrosis in chronic hepatitis C virus infection

Archives of Medical Science

Volumn 6, Issue 3, 2010, Pages 356-365

  Zakaria, Sohier ^a   Youssef, Magdy ^b   Moussa, Mona ^c   Akl, Maha ^c   El Ahwany, Eman ^d   El Raziky, Maysa ^a   Mostafa, Omaima ^b   Helmy, Ahmed Hazem ^e   El Hindawi, Ali ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

^c Theodor Bilharz Research Institute   (Egypt)

^d Giza   (Egypt)

^e Egypt   (Egypt)

Author keywords

smooth muscle actin; Chronic hepatitis C; Fibrosis; Glial fibrillary acidic protein; Stellate cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; SCHISTOSOMIASIS; STELLATE CELL;

EID: 77954290950     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.14255     Document Type: Article

References (51)

1. Mirmomen S, Alavian S, Hajarizadeh B, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in iran: a multicenter study. Arch iran Med 2006; 9: 319-23.
2. Strickland G, Elhefni H, Salman T, et al. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 2002; 67: 436-42. (Pubitemid 35303870)
3. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-32.
4. Codes L, Matos L, Paraná R. Chronic hepatitis C and fibrosis: evidences for possible estrogen benefits. Braz J infect Dis 2007; 11: 371-4. (Pubitemid 47616503)
5. Chitsulo L, Engels D, Montresor A, et al. The global status of schistosomiasis and its control. Acta Trop 2000; 77: 41-55.
6. Andrade ZA. Schistosomal hepatopathy. Mem inst Oswaldo Cruz 2004; 99: 51-7.
7. Senoo H, Sato M, Imai K. Hepatic stellate cells from the viewpoint of retinoid handling and function of the extracellular matrix. Kaibogaku Zasshi 1997; 72: 79-94.
8. Friedman SL. Hepatic stellate cells: protean, multi-functional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125-72.
9. Guido M, Rugge M, Leandro G, et al. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts. Hepatology 1997; 26: 310-4. (Pubitemid 27328306)
10. Carpino G, Morini S, Corradini SG, et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis 2005; 37: 349-56.
11. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 1994; 63: 345-82.
12. Cassiman D, Libbrecht L, Desmet V, et al. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002; 36: 200-9.
13. Chang D, Ramalho LN, Ramalho FS, et al. Hepatic stellate cells in human Schistosomiasis mansoni: a comparative immunohistochemical study with liver cirrhosis. Acta Trop 2006; 97: 318-23. (Pubitemid 43295720)
14. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at: http://www.wma.net/e/policy/pdf/17c.pdf Accessed September 4, 2008.
15. Saber M, Omar M, Badawi H, et al. Comparative studies in serological diagnosis of hepatitis C virus (HCV) infection. J Hep Gast inf Dis 1995; 3: 47-51.
16. The French METAVIR Cooperative Study Group. intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
17. Carotti S, Morini S, Corradini SG, et al. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transplant 2008; 14: 806-14.
18. Akpolat N, Yashi S, Godekmerdan A, et al. The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study. Histopathology 2005; 47: 276-80. (Pubitemid 41243265)
19. Nieto N, Friedman S, Cederbaum A. Cytochrom P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen 1 protein synthesis by hepatic stellate cells. J Biol Chem 2002; 277: 9853-64. (Pubitemid 34968090)
20. Wu J, Zern M. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000; 35: 666-72.
21. Dooley S, Delvoux B, Streckert M, et al. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. FEBS Lett 2001; 502: 4-10.
22. Gutlerrez-Rutz M, Robles-Dlaz G, Kershenobich D. Emerging concepts in inflammation and fibrosis. Arch Med Res 2002; 33: 595-9.
23. Kweon Y, Goodman Z, Diestang J, et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol 2001; 35: 749-55. (Pubitemid 34717666)
24. Nakatani K, Seki S, Kawada N, et al. Expression of SPARC by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis. Virchows Arch 2002; 441: 466-74. (Pubitemid 35430462)
25. Mann DA, Smart DE. Transcriptional regulation of hepatic stellate cell activation. Gut 2002; 50: 891-9.
26. Martinelli A, Ramalho L, Zucoloto S. Hepatic stellate cells in hepatitis C patients: relationship with liver iron deposits and severity of liver disease. J Gastroenterol Hepatol 2004; 19: 91-8. (Pubitemid 38130613)
27. Skalli O, Ropraz P, Trzeciak A, et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986; 103: 2787-96. (Pubitemid 17008024)
28. Schmitt-Graff A, Kruger S, Bochard F, et al. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991; 138: 1233-42.
29. Hautekeete M, Geerts A. The hepatic stellate (ito) cell: its role in human liver disease. Virchows Arch 1997; 430: 195-207. (Pubitemid 27151929)
30. Levy MT, McCaughan G, Marinos G, et al. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver 2002; 22: 93-101. (Pubitemid 34591248)
31. Sakaida I, Nagatomi A, Hironaka K, et al. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy. Am J Gastroenterol 1999; 94: 489-96. (Pubitemid 29084675)
32. Russo MW, Firpi RJ, Nelson DR, et al. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C. Liver Transplant 2005; 11: 1235-41.
33. Gawrieh S, Papouchado B, Burgart L, et al. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation. Liver Transplant 2005; 11: 1207-13. (Pubitemid 41511934)
34. Chang KM. Immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 2003; 7: 89-105.
35. Mizukoshi E, Rehermann B. Immune responses and immunity in hepatitis C virus infection. J Gastroenterol 2001; 36: 799-808. (Pubitemid 34036902)
36. Heinzel F, Sadick M, Holaday B, et al. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis: Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989; 169: 59-72. (Pubitemid 19035542)
37. + effectors cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med 1994; 179: 1367-71.
38. Shi Z, Wakil A, Rockey D. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 1997; 94: 10663-8.
39. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005; 50: 427-34.
40. Carpino F, Gaudio E, Marinizzi G, et al. A scanning and transmission electron microscopic study of experimental extrahepatic cholestasis in the rat. J Submicrosc Cytol 1981; 13: 581-98.
41. Blomhoff R, Wake K. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J 1991; 5: 271-7.
42. Buniatian G, Gebhardt R, Schrenk D, et al. Colocalization of three types of intermediate filament proteins in perisinusoidal stellate cells: glial fibrillary acidic protein as a new cellular marker. Eur J Cell Biol 1996; 70: 23-32.
43. Geerts A. History, heterogeneity, developmental biology and functions of quiescent hepatic stellate cells. Semin Liver Dis 2001; 21: 311-35.
44. Niki T, De Bleser P, Xu G, et al. Comparison of glial fibrillary acidic protein and desmin staining in normal and CC14-induced fibrotic rat livers. Hepatology 1996; 23: 1538-45. (Pubitemid 26181238)
45. Geerts A, Lazou J, De Belser P, et al. Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver. Hepatology 1991; 13: 1193-202.
46. Milani S, Herbst H, Schuppan D. In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in non parenchymal liver cells. Hepatology 1989; 10: 84-92.
47. Nakatsukasa H, Nagy P, Evarts RP, et al. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin invest 1990; 85: 1833-43. (Pubitemid 20192957)
48. Niki T, Pekny M, Hellemans K, et al. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology 1999; 29: 520-7. (Pubitemid 29088457)
49. Levy MT, McCaughan GW, Abbott CA, et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology 1999; 29: 1768-78.
50. Barbosa Jr, Pfeifer U, Andrade Z. Role of fat-storing cells in schistosomal hepatic fibrosis of mice. Virchows Arch B Cell Pathol incl Mol Pathol 1993; 64: 91-6. (Pubitemid 23246554)
51. Boloukhere M, Baldo-Correa E, Borojevic R. Experimental schistosomiasis mansoni: characterization of connective tissue cells in hepatic periovular granulomas. J Submicrosc Cytol Pathol 1993; 25: 505-17.